These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38411946)

  • 21. Oncolytic specificity of Newcastle disease virus is mediated by selectivity for apoptosis-resistant cells.
    Mansour M; Palese P; Zamarin D
    J Virol; 2011 Jun; 85(12):6015-23. PubMed ID: 21471241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy inhibition suppresses Newcastle disease virus-induced cell death by inhibiting viral replication in human breast cancer cells.
    Rozilah MI; Yusoff K; Chia SL; Ismail S
    Virology; 2024 Feb; 590():109957. PubMed ID: 38100982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance.
    Schirrmacher V
    Expert Opin Biol Ther; 2015; 15(12):1757-71. PubMed ID: 26436571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes.
    Chan LC; Kalyanasundram J; Leong SW; Masarudin MJ; Veerakumarasivam A; Yusoff K; Chan SC; Chia SL
    BMC Cancer; 2021 May; 21(1):625. PubMed ID: 34044804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different responses of human pancreatic adenocarcinoma cell lines to oncolytic Newcastle disease virus infection.
    Buijs PR; van Eijck CH; Hofland LJ; Fouchier RA; van den Hoogen BG
    Cancer Gene Ther; 2014 Jan; 21(1):24-30. PubMed ID: 24384773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiling in PC12 cells infected with an oncolytic Newcastle disease virus strain.
    Balogh A; Bátor J; Markó L; Németh M; Pap M; Sétáló G; Müller DN; Csatary LK; Szeberényi J
    Virus Res; 2014 Jun; 185():10-22. PubMed ID: 24637408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined therapy of oncolytic Newcastle disease virus and rhizomes extract of Rheum ribes enhances cancer virotherapy in vitro and in vivo.
    Al-Shammari AM; Jalill RDA; Hussein MF
    Mol Biol Rep; 2020 Mar; 47(3):1691-1702. PubMed ID: 31970625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.
    Abdullahi S; Jäkel M; Behrend SJ; Steiger K; Topping G; Krabbe T; Colombo A; Sandig V; Schiergens TS; Thasler WE; Werner J; Lichtenthaler SF; Schmid RM; Ebert O; Altomonte J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncolytic therapy and gene therapy for cancer: recent advances in antitumor effects of Newcastle disease virus.
    Huang Z; Liu M; Huang Y
    Discov Med; 2020; 30(159):39-48. PubMed ID: 33357361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress in using Newcastle disease virus for tumor therapy: a review].
    Wu Y; Hao J; Li D
    Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1031-6. PubMed ID: 21090105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF-κB pathway in canine mammary carcinoma cells.
    Wang J; Li M; Li M
    Vet Comp Oncol; 2023 Sep; 21(3):520-532. PubMed ID: 37282822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATM-mediated DNA double-strand break response facilitated oncolytic Newcastle disease virus replication and promoted syncytium formation in tumor cells.
    Ren S; Ur Rehman Z; Gao B; Yang Z; Zhou J; Meng C; Song C; Nair V; Sun Y; Ding C
    PLoS Pathog; 2020 Jun; 16(6):e1008514. PubMed ID: 32479542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human renal carcinoma cells respond to Newcastle disease virus infection through activation of the p38 MAPK/NF-κB/IκBα pathway.
    Ch'ng WC; Abd-Aziz N; Ong MH; Stanbridge EJ; Shafee N
    Cell Oncol (Dordr); 2015 Aug; 38(4):279-88. PubMed ID: 25930675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model.
    Yurchenko KS; Glushchenko AV; Gulyaeva MA; Bi Y; Chen J; Shi W; Adamenko LS; Shestopalov AM
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33806229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The oncolytic activity of Newcastle disease virus NDV-HUJ on chemoresistant primary melanoma cells is dependent on the proapoptotic activity of the inhibitor of apoptosis protein Livin.
    Lazar I; Yaacov B; Shiloach T; Eliahoo E; Kadouri L; Lotem M; Perlman R; Zakay-Rones Z; Panet A; Ben-Yehuda D
    J Virol; 2010 Jan; 84(1):639-46. PubMed ID: 19864394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review on comprehending immunotherapeutic approaches inducing ferroptosis: Managing tumour immunity.
    Chattopadhyay S; Hazra R; Mallick A; Gayen S; Roy S
    Immunology; 2024 Aug; 172(4):547-565. PubMed ID: 38566448
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rac1 is required for oncolytic NDV replication in human cancer cells and establishes a link between tumorigenesis and sensitivity to oncolytic virus.
    Puhlmann J; Puehler F; Mumberg D; Boukamp P; Beier R
    Oncogene; 2010 Apr; 29(15):2205-16. PubMed ID: 20101224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma.
    Vijayakumar G; Palese P; Goff PH
    EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells.
    Wang X; Shao X; Gu L; Jiang K; Wang S; Chen J; Fang J; Guo X; Yuan M; Shi J; Ding C; Meng S; Xu Q
    J Cell Mol Med; 2020 Apr; 24(7):4286-4297. PubMed ID: 32100392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.